Dr. Fradley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd -- PCAM
3rd Floor
Philadelphia, PA 19104Phone+1 215-662-7700Fax+1 215-349-5533
Education & Training
- Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2008 - 2011
- Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
- PA State Medical License 2020 - 2024
- FL State Medical License 2013 - 2021
- MA State Medical License 2008 - 2014
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy Start of enrollment: 2014 Nov 01
- Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- Are Cardiovascular Complications the Achilles' Heel of Osimertinib?Nicholas S Wilcox, Michael G Fradley
JAMA Network Open. 2024-12-02 - Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines.Takeshi Onoue, Andrew H Matthews, Azin Vakilpour, Yu Kang, Bénédicte Lefebvre
Cardio-Oncology. 2024-11-01 - Incidence and Predictors of Pacing-Induced Right Ventricular Cardiomyopathy.Thomas A Boyle, Naga Venkata K Pothineni, Melissa Austin, Poojita Shivamurthy, Timothy Markman
Circulation. Arrhythmia and Electrophysiology. 2024-10-01
Press Mentions
- Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk PatientsDecember 12th, 2024
- Heart Failure Risk Lingers Long After Chemotherapy, Regardless of DoseFebruary 3rd, 2023
- Cardio-Oncology Topics from AHA 2020August 17th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: